Multicenter Study for Defining the Breakpoint for Rifampin Resistance in Neisseria meningitidis by rpoB Sequencing (cid:1)

Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number ( n (cid:1) 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of > 0.25 mg/liter ( n (cid:1) 161) received by the national reference laboratories for meningococci in the participating countries. Representative isolates displaying rifampin MICs of <0.25 mg/liter were also examined ( n (cid:1) 231). Typing of isolates was performed, and a 660-bp DNA fragment of the rpoB gene was sequenced. Sequences differing by at least one nucleotide were defined as unique rpoB alleles. The geometric mean of the MICs was calculated for isolates displaying the same allele. The clinical isolates displaying rifampin MICs of >1 mg/liter possessed rpoB alleles with nonsynonymous mutations at four critical amino acid residues, D542, H552, S548, and S557, that were absent in the alleles found in all isolates with MICs of < 1 mg/liter. Rifampin-susceptible isolates could be defined as those with MICs of < 1 mg/liter.

[1]  M. Taha,et al.  Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  P. Klatser,et al.  Specific mutations in the Mycobacterium tuberculosis rpoB gene are associated with increased dnaE2 expression. , 2007, FEMS microbiology letters.

[3]  F. Guillou,et al.  Transgenic Mice Expressing Human Transferrin as a Model for Meningococcal Infection , 2007, Infection and Immunity.

[4]  Keith A. Jolley,et al.  Target Gene Sequencing To Characterize the Penicillin G Susceptibility of Neisseria meningitidis , 2007, Antimicrobial Agents and Chemotherapy.

[5]  M. Taha,et al.  Rifampin-resistant Neisseria meningitidis , 2006, Emerging infectious diseases.

[6]  M. A. Diggle,et al.  Automation of MLST using third-generation liquid-handling technology , 2006, Molecular biotechnology.

[7]  D. Huson,et al.  Application of phylogenetic networks in evolutionary studies. , 2006, Molecular biology and evolution.

[8]  Naohiro Matsugaki,et al.  Allosteric Modulation of the RNA Polymerase Catalytic Reaction Is an Essential Component of Transcription Control by Rifamycins , 2005, Cell.

[9]  S. Gillespie,et al.  Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution? , 2005, The Journal of antimicrobial chemotherapy.

[10]  Edward C. Holmes,et al.  Distribution of Surface Protein Variants among Hyperinvasive Meningococci: Implications for Vaccine Design , 2004, Infection and Immunity.

[11]  D. Caugant,et al.  Neisseria meningitidis: an overview of the carriage state. , 2004, Journal of medical microbiology.

[12]  M. Taha,et al.  Continuing Diversification of Neisseria meningitidis W135 as a Primary Cause of Meningococcal Disease after Emergence of the Serogroup in 2000 , 2004, Journal of Clinical Microbiology.

[13]  P. Bennett,et al.  Rifampicin resistance and its fitness cost in Enterococcus faecium. , 2004, The Journal of antimicrobial chemotherapy.

[14]  O. Nolte,et al.  Description of new mutations in the rpoB gene in rifampicin-resistant Neisseria meningitidis selected in vitro in a stepwise manner. , 2003, Journal of medical microbiology.

[15]  P. Kriz,et al.  Interlaboratory Comparison of Agar Dilution and Etest Methods for Determining the MICs of Antibiotics Used in Management of Neisseria meningitidis Infections , 2003, Antimicrobial Agents and Chemotherapy.

[16]  Martin C J Maiden,et al.  Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. , 2003, Microbiology.

[17]  D. Baldwin,et al.  Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy. , 2002, The Journal of antimicrobial chemotherapy.

[18]  M. A. Diggle,et al.  Rapid assignment of nucleotide sequence data to allele types for multi-locus sequence analysis (MLSA) of bacteria using an adapted database and modified alignment program. , 2002, Journal of molecular microbiology and biotechnology.

[19]  A. Deghmane,et al.  The duality of virulence and transmissibility in Neisseria meningitidis. , 2002, Trends in microbiology.

[20]  K. Murakami,et al.  Structural Basis of Transcription Initiation: An RNA Polymerase Holoenzyme-DNA Complex , 2002, Science.

[21]  K. Murakami,et al.  Structural Basis of Transcription Initiation: RNA Polymerase Holoenzyme at 4 Å Resolution , 2002, Science.

[22]  M. A. Diggle,et al.  Semiautomation of Multilocus Sequence Typing for the Characterization of Clinical Isolates of Neisseria meningitidis , 2001, Journal of Clinical Microbiology.

[23]  P. Kriz,et al.  Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. , 2001, The Journal of antimicrobial chemotherapy.

[24]  G. La Rosa,et al.  Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. , 2001, The Journal of antimicrobial chemotherapy.

[25]  S. Salzberg,et al.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. , 2000, Science.

[26]  M. Achtman,et al.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Pennington,et al.  Molecular characterization of rifampin-resistant Neisseria meningitidis , 1994, Antimicrobial Agents and Chemotherapy.

[28]  S. Goodman,et al.  Identification and arrangement of the DNA sequence recognized in specific transformation of Neisseria gonorrhoeae. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Frei,et al.  The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[31]  J. Poolman,et al.  Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. , 1988, Microbial pathogenesis.